- Home
- RCKT vs ESRT Comparison
RCKT vs ESRT Comparison
Compare RCKT & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- ESRT
- Stock Information
- Founded
- RCKT 1999
- ESRT 2011
- Country
- RCKT United States
- ESRT United States
- Employees
- RCKT N/A
- ESRT N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- ESRT Real Estate Investment Trusts
- Sector
- RCKT Health Care
- ESRT Real Estate
- Exchange
- RCKT Nasdaq
- ESRT Nasdaq
- Market Cap
- RCKT 1.9B
- ESRT 1.8B
- IPO Year
- RCKT N/A
- ESRT 2013
- Fundamental
- Price
- RCKT $18.43
- ESRT $11.43
- Analyst Decision
- RCKT Strong Buy
- ESRT Hold
- Analyst Count
- RCKT 9
- ESRT 3
- Target Price
- RCKT $53.22
- ESRT $10.33
- AVG Volume (30 Days)
- RCKT 1.1M
- ESRT 1.0M
- Earning Date
- RCKT 11-04-2024
- ESRT 10-21-2024
- Dividend Yield
- RCKT N/A
- ESRT 1.22%
- EPS Growth
- RCKT N/A
- ESRT N/A
- EPS
- RCKT N/A
- ESRT 0.26
- Revenue
- RCKT N/A
- ESRT $755,130,000.00
- Revenue This Year
- RCKT N/A
- ESRT N/A
- Revenue Next Year
- RCKT $300.20
- ESRT $3.15
- P/E Ratio
- RCKT N/A
- ESRT $43.69
- Revenue Growth
- RCKT N/A
- ESRT 4.86
- 52 Week Low
- RCKT $15.98
- ESRT $7.34
- 52 Week High
- RCKT $32.53
- ESRT $11.62
- Technical
- Relative Strength Index (RSI)
- RCKT 53.10
- ESRT 66.09
- Support Level
- RCKT $16.57
- ESRT $10.83
- Resistance Level
- RCKT $17.43
- ESRT $11.50
- Average True Range (ATR)
- RCKT 0.89
- ESRT 0.23
- MACD
- RCKT 0.17
- ESRT 0.03
- Stochastic Oscillator
- RCKT 84.80
- ESRT 81.73
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.